A finalized federal rule will bar Medicaid and CHIP from reimbursing gender-affirming care for minors starting Oct. 13 — and California, one of the states where that care is still legal, has already staged $56 million in state money to keep providers afloat.

The Centers for Medicare & Medicaid Services finalized a rule this month cutting off all federal Medicaid dollars for gender-affirming hormones and surgeries for people under 18, and CHIP dollars for those under 19. For California families on Medi-Cal, the practical question isn't whether the care remains legal — it does — but whether anyone will pay for it. State lawmakers, anticipating the cut, budgeted $26 million specifically for trans-health providers plus a $30 million fund for care Medi-Cal no longer covers. Whether that backstop holds, and whether courts block the rule first, will decide what happens to an estimated tens of thousands of trans minors nationally.

The rule CMS finalized this month (external source, opens in a new tab) has been in the works for more than a year. Its terms are narrow but blunt: no Medicaid reimbursement for gender-affirming hormones or surgeries for anyone under 18, and no Children's Health Insurance Program money for anyone under 19, as public-radio outlet LAist reported. Mental-health services for trans youth are untouched. Existing hormone regimens get a limited tapering window. States may keep offering the care — they just won't be repaid the federal share for it.

That distinction lands hard in California, which never banned the care. Health-policy nonprofit KFF estimates roughly 130,000 transgender people under 18 live in states where gender-affirming treatment remains available — and California is one of the largest. Losing the federal match doesn't outlaw a single prescription here; it removes the money that pays for it.

We need it really badly right now," she told NPR, adding that her husband remains out of work.

State officials saw the cut coming. In the budget Gov. Gavin Newsom signed in June, lawmakers set aside $26 million in one-time money aimed directly at trans-health providers, plus a separate $30 million fund for care Medi-Cal reimbursement no longer covers, LAist reported. Los Angeles LGBT Center CEO Joe Hollendoner, who lobbied for the money, called the appropriations "historic investments" that give the state its own resources to keep the care going as federal dollars vanish, in a statement to the outlet.

Advocates are less sure the money erases the fear. The rule "ignores the science," Kathie Moehlig, executive director of TransFamily Support Services, said in a statement to LAist, and drops politics into decisions that belong to trans young people, their parents and their doctors.

The human toll is already showing. In a report from NPR, republished by KQED, a longtime Republican mother in California — identified only by her initials, A.W., out of concern her family could become a target — described leaning on the coverage for her transgender teenager. "We need it really badly right now," she told NPR, adding that her husband remains out of work. The KFF figure of 130,000 comes from that same report.

The rule isn't the last word. California Attorney General Rob Bonta joined a 21-state coalition opposing the proposal during rulemaking, arguing HHS exceeded its authority (external source, opens in a new tab) and intruded on states' power to regulate medicine. The ACLU and Lambda Legal have signaled for months they will sue, and the vast majority of public comments filed during the rulemaking opposed the rule, LAist reported. Ariela Cuellar of the California LGBTQ Health and Human Services Network called it "a wake up call for states to take aggressive actions to protect essential medical care."

If no judge blocks it, the rule takes effect Oct. 13 — leaving California's $56 million bet as the thing standing between the federal cut and the exam room.